Dr. Bodyl Brand (Oxford University, UK) joins AJP Audio to discuss the effectiveness of menopausal hormone therapy in preventing psychosis relapse in women with schizophrenia and schizoaffective disorder. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin takes us through the rest of the October issue of the American Journal of Psychiatry, which focuses on other issues touching psychosis and schizophrenia spectrum disorders.

01:05 Brand interview
03:08 MHT and potential side effects in schizophrenia treatment
06:16 Estrogen and psychosis prophylaxis
07:44 MHT effectiveness
10:15 Clinical implications
11:27 Strengths and limitations
13:47 The need for further study
15:54 Further research
17:24 Kalin interview
17:47 Brand et al.
20:17 Partanen et al.
23:54 Moran et al.
26:48 Gallucci et al.
30:38 Arion et al.

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at ajp@psych.org

October 2024: Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective Disorder

American Journal of Psychiatry Audio